--- title: "Hybridoma Technology | Microbiology" description: "Hybridoma technology creates immortal cells that produce one monoclonal antibody, a core microbiology method for diagnostics, research, and therapy." canonical: "https://fiveable.me/microbio/key-terms/hybridoma-technology" type: "key-term" subject: "Microbiology" unit: "Unit 20" --- # Hybridoma Technology | Microbiology ## Definition Hybridoma technology is a microbiology method for making monoclonal antibodies by fusing a B cell with a myeloma cell. The hybrid cell, called a hybridoma, can grow forever and keep making one specific antibody. ## What It Is Hybridoma technology is the lab method microbiology uses to make a single, highly specific monoclonal antibody in large amounts. The basic idea is simple: take a B cell that makes the antibody you want, then fuse it with a myeloma cell that can divide indefinitely. The fused cell, a hybridoma, combines both traits, so it keeps producing the same antibody over and over. The B cell is the part that gives specificity. It comes from an immune response and already makes antibody against one epitope on an antigen. The problem is that normal B cells do not live long in culture, so by themselves they cannot supply a steady antibody source. That is where the myeloma cell comes in, because cancerous plasma-line cells can keep dividing without stopping. After fusion, not every cell in the mixture is useful. Some cells do not fuse, some fuse in the wrong way, and only a few hybrid cells have the exact combination scientists want. So the culture is selected and screened until one hybridoma line is found that secretes the target antibody. Once that clone is identified, it can be expanded into a pure cell population. This is why hybridoma technology is tied to monoclonal antibodies instead of polyclonal serum. Polyclonal antibodies come from many B cell clones and bind multiple epitopes, while a hybridoma line gives you one antibody from one clone. That makes the product much more uniform, which matters when you need consistent binding in a test or treatment. In microbiology, you often see this method used as part of the broader study of immunity, diagnostics, and biotechnology. If a lab wants to detect a pathogen, measure a toxin, or tag a microbial protein in an experiment, a monoclonal antibody from a hybridoma can provide the same binding pattern every time. That consistency is what makes the technology so useful. ## Why It Matters Hybridoma technology shows how microbiology turns an immune response into a practical lab tool. Instead of relying on a mixed antibody sample from serum, scientists can make one antibody with one binding target, which gives much cleaner results in tests and experiments. This matters any time you need specificity. A monoclonal antibody can be built into assays that detect tiny amounts of a microbial antigen, and it can also be used in research to label a particular protein without a lot of background noise. In a course setting, that means hybridomas sit right at the intersection of immunology, cell biology, and biotechnology. It also helps you connect two big cell traits, specificity and immortality. The B cell supplies the exact antibody, and the myeloma cell supplies endless growth. If you understand that tradeoff, the whole method makes sense instead of feeling like a memorized list of steps. Hybridoma technology is also a good example of why cloning matters. Once one good hybridoma is isolated, every cell in that line makes the same antibody, which is why the final product is called monoclonal. That idea comes up again whenever your class compares pure cell lines to mixed populations. ## Connections ### Monoclonal Antibody Hybridoma technology is the classic way to produce a monoclonal antibody. The hybridoma is the cell factory, while the monoclonal antibody is the actual product you collect and use. If you see a question about a single antibody that binds one epitope, this is the output to connect back to the method that made it. ### B Cell The B cell contributes antigen specificity to the hybridoma. It is the immune cell that already knows how to make the antibody you want, but it cannot divide forever in culture. That is why the B cell has to be fused with a myeloma cell instead of being grown on its own. ### Myeloma Cell A myeloma cell gives the hybridoma its immortality. By itself, it can keep dividing, but it does not provide the target antibody specificity that a B cell does. The power of hybridoma technology is in combining the two cell types so the final line both survives and secretes the desired antibody. ### [Cell Fusion](/microbio/key-terms/cell-fusion) Cell fusion is the actual step that creates the hybridoma. The B cell and myeloma cell are merged into one cell so their useful traits end up in the same line. If the fusion does not work well, you do not get a stable antibody-producing hybridoma, which is why selection comes right after fusion. ## On the AP Exam A quiz or lab question may show the steps of hybridoma technology and ask you to identify which cell gives specificity, which cell gives unlimited growth, and why the fused cell is selected. You may also see a scenario about producing a diagnostic antibody for a microbial antigen and need to explain why a monoclonal antibody is better than antiserum. If the question gives you a blot, assay, or antibody-based test, trace how the hybridoma makes the result consistent. The main move is to connect cell fusion to one antibody clone, then connect that clone to a uniform signal in the assay. When you can explain why only one hybridoma line is kept, you are showing that you understand the mechanism, not just the vocabulary. ## Hybridoma Technology vs antiserum Antiserum is a mixed antibody preparation taken from an immunized animal, so it contains many antibodies against different epitopes. Hybridoma technology makes a monoclonal antibody from one selected cell line, so the result is much more specific and uniform. If a question asks about a single epitope target, hybridoma is the better match. ## Key Takeaways - Hybridoma technology makes monoclonal antibodies by fusing a specific B cell with an immortal myeloma cell. - The B cell supplies antibody specificity, and the myeloma cell supplies unlimited division in culture. - After fusion, scientists select one stable hybridoma clone so every cell in the line makes the same antibody. - This method matters because monoclonal antibodies give cleaner, more consistent results than mixed antibody samples. - In microbiology, hybridomas show up in diagnostics, research assays, and therapy-linked antibody production. ## FAQs ### What is hybridoma technology in Microbiology? Hybridoma technology is a method for making monoclonal antibodies by fusing an antibody-producing B cell with a myeloma cell. The fused hybridoma can divide indefinitely and keep making one specific antibody. In microbiology, that makes it a standard way to produce precise antibody tools for testing and research. ### Why do you fuse a B cell with a myeloma cell? You fuse them to combine two traits that do not exist together in a normal cell. The B cell gives the antibody’s specificity, while the myeloma cell gives unlimited growth. Without the fusion, the B cell would not survive long enough to produce large amounts of antibody. ### How is a hybridoma different from antiserum? A hybridoma produces one monoclonal antibody from one selected clone, so the product is very uniform. Antiserum contains polyclonal antibodies from many B cell clones, so it recognizes multiple epitopes. That makes antiserum broader, but less specific than a hybridoma-derived antibody. ### Where is hybridoma technology used? It is used in diagnostic tests, research assays, and antibody-based therapies or screening tools. In microbiology, you might use a hybridoma-derived antibody to detect a pathogen antigen or to label a microbial protein in an experiment. The main advantage is consistent binding from batch to batch. ## Related Study Guides - [20.1 Polyclonal and Monoclonal Antibody Production](/microbio/unit-20/1-polyclonal-monoclonal-antibody-production/study-guide/VOVWiT06VLLauY7q) ## About This Document Canonical Fiveable pages are available as Markdown at the same path plus `.md`. - [llms.txt](https://fiveable.me/llms.txt): index of Fiveable's sections and URL patterns - [llms-full.txt](https://fiveable.me/llms-full.txt): complete subject and unit listing - [MCP server](https://fiveable.me/mcp): call Fiveable as tools instead of fetching pages (`https://fiveable.me/api/mcp`) - [MCP server for AP teachers](https://fiveable.me/mcp/teachers): a teacher's classes, assignments and AP-rubric grading (`https://fiveable.me/api/mcp/teacher`) ## Structured Data ```json {"@context":"https://schema.org","@graph":[{"@type":"LearningResource","@id":"https://fiveable.me/microbio/key-terms/hybridoma-technology#resource","name":"Hybridoma Technology | Microbiology","url":"https://fiveable.me/microbio/key-terms/hybridoma-technology","learningResourceType":"Concept explainer","educationalLevel":"AP® / High School","about":{"@id":"https://fiveable.me/microbio/key-terms/hybridoma-technology#term"},"audience":{"@type":"EducationalAudience","educationalRole":"student"},"dateModified":"2026-07-03T02:23:49.054Z","isPartOf":{"@type":"Collection","name":"Microbiology Key Terms","url":"https://fiveable.me/microbio/key-terms"},"publisher":{"@type":"Organization","name":"Fiveable","url":"https://fiveable.me"}},{"@type":"DefinedTerm","@id":"https://fiveable.me/microbio/key-terms/hybridoma-technology#term","name":"Hybridoma Technology","description":"Hybridoma technology is a microbiology method for making monoclonal antibodies by fusing a B cell with a myeloma cell. The hybrid cell, called a hybridoma, can grow forever and keep making one specific antibody.","url":"https://fiveable.me/microbio/key-terms/hybridoma-technology","inDefinedTermSet":{"@type":"DefinedTermSet","name":"Microbiology Key Terms","url":"https://fiveable.me/microbio/key-terms"}},{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"What is hybridoma technology in Microbiology?","acceptedAnswer":{"@type":"Answer","text":"Hybridoma technology is a method for making monoclonal antibodies by fusing an antibody-producing B cell with a myeloma cell. The fused hybridoma can divide indefinitely and keep making one specific antibody. In microbiology, that makes it a standard way to produce precise antibody tools for testing and research."}},{"@type":"Question","name":"Why do you fuse a B cell with a myeloma cell?","acceptedAnswer":{"@type":"Answer","text":"You fuse them to combine two traits that do not exist together in a normal cell. The B cell gives the antibody’s specificity, while the myeloma cell gives unlimited growth. Without the fusion, the B cell would not survive long enough to produce large amounts of antibody."}},{"@type":"Question","name":"How is a hybridoma different from antiserum?","acceptedAnswer":{"@type":"Answer","text":"A hybridoma produces one monoclonal antibody from one selected clone, so the product is very uniform. Antiserum contains polyclonal antibodies from many B cell clones, so it recognizes multiple epitopes. That makes antiserum broader, but less specific than a hybridoma-derived antibody."}},{"@type":"Question","name":"Where is hybridoma technology used?","acceptedAnswer":{"@type":"Answer","text":"It is used in diagnostic tests, research assays, and antibody-based therapies or screening tools. In microbiology, you might use a hybridoma-derived antibody to detect a pathogen antigen or to label a microbial protein in an experiment. The main advantage is consistent binding from batch to batch."}}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Microbiology","item":"https://fiveable.me/microbio"},{"@type":"ListItem","position":2,"name":"Key Terms","item":"https://fiveable.me/microbio/key-terms"},{"@type":"ListItem","position":3,"name":"Unit 20","item":"https://fiveable.me/microbio/unit-20"},{"@type":"ListItem","position":4,"name":"Hybridoma Technology"}]}]} ```